ReviewJournal for immunotherapy of cancer2022

Time to evolve: predicting engineered T cell-associated toxicity with next-generation models.

Emmanuel Donnadieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.